True endpoint reduction by surrogate endpoints
From MaRDI portal
Recommendations
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
- The evaluation of surrogate endpoints.
Cites work
- A mean score method for missing and auxiliary covariate data in regression models
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- Inference using surrogate outcome data and a validation sample
- Information Recovery in a Study With Surrogate Endpoints
- Linear increment in efficiency with the inclusion of surrogate endpoint
- Miscellanea. A robust imputation method for surrogate outcome data
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
Cited in
(2)
This page was built for publication: True endpoint reduction by surrogate endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4638854)